|
Avaliação ADITXT, Inc. (ADTX) DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Aditxt, Inc. (ADTX) Bundle
UNLEASH Aditxt, Inc. (ADTX) True Potendent com nossa calculadora DCF avançada! Ajuste as principais suposições, explore vários cenários e avalie como as flutuações afetam a avaliação do Aditxt, Inc. (ADTX)-tudo dentro de um modelo de excelente fácil de usar.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .1 | .9 | .6 | .8 | .9 | 1.0 | 1.2 | 1.4 |
| Revenue Growth, % | 0 | 0 | 0 | 788.96 | -30.9 | 17.27 | 17.27 | 17.27 | 17.27 | 17.27 |
| EBITDA | .0 | -8.9 | -44.0 | -24.8 | -25.5 | -.2 | -.2 | -.2 | -.2 | -.3 |
| EBITDA, % | 100 | 100 | -41849.84 | -2659.04 | -3945.89 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | 5.9 | .0 | .5 | .5 | .5 | .7 | .8 | .9 | 1.1 | 1.3 |
| Depreciation, % | 100 | 100 | 453.41 | 57.4 | 84.1 | 88.3 | 88.3 | 88.3 | 88.3 | 88.3 |
| EBIT | -5.8 | -8.9 | -44.4 | -25.4 | -26.0 | -.2 | -.2 | -.2 | -.2 | -.3 |
| EBIT, % | 100 | 100 | -42303.25 | -2716.44 | -4029.99 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | .0 | 10.5 | 7.9 | 2.8 | .1 | .6 | .7 | .9 | 1.0 | 1.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .6 | .5 | 5.9 | .7 | .8 | 1.0 | 1.1 | 1.3 |
| Account Receivables, % | 100 | 100 | 561.57 | 56.54 | 907.19 | 91.31 | 91.31 | 91.31 | 91.31 | 91.31 |
| Inventories | .0 | .0 | .5 | 1.0 | .7 | .8 | .9 | 1.0 | 1.2 | 1.4 |
| Inventories, % | 100 | 100 | 470.99 | 101.75 | 115.55 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 1.8 | .2 | 1.6 | 2.0 | 8.6 | .8 | .9 | 1.0 | 1.2 | 1.4 |
| Accounts Payable, % | 100 | 100 | 1500.03 | 209.75 | 1325.99 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | -.2 | -1.0 | -.4 | .0 | -.2 | -.3 | -.3 | -.3 | -.4 |
| Capital Expenditure, % | 100 | 100 | -967.07 | -39.31 | -2.23 | -28.31 | -28.31 | -28.31 | -28.31 | -28.31 |
| Tax Rate, % | 0.02966307 | 0.02966307 | 0.02966307 | 0.02966307 | 0.02966307 | 0.02966307 | 0.02966307 | 0.02966307 | 0.02966307 | 0.02966307 |
| EBITAT | -5.8 | -9.2 | -46.3 | -25.9 | -26.0 | -.2 | -.2 | -.2 | -.2 | -.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 1.9 | -10.9 | -46.6 | -25.7 | -24.0 | -2.3 | .2 | .3 | .3 | .4 |
| WACC, % | 35.05 | 35.05 | 35.05 | 35.05 | 35.04 | 35.05 | 35.05 | 35.05 | 35.05 | 35.05 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 1 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | 18 | |||||||||
| Equity Value | -19 | |||||||||
| Diluted Shares Outstanding, MM | 0 | |||||||||
| Equity Value Per Share | -63.41 |
What You Will Receive
- Comprehensive Financial Model: Aditxt, Inc.’s (ADTX) actual data facilitates accurate DCF valuation.
- Complete Forecasting Control: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates provide immediate results as adjustments are made.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation needs.
- Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.
Key Features
- Comprehensive ADTX Data: Pre-filled with Aditxt, Inc.'s historical performance metrics and future projections.
- Customizable Inputs: Modify growth rates, profit margins, discount rates, tax implications, and capital investments.
- Interactive Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value based on your customized inputs.
- Scenario Analysis: Generate various forecasting scenarios to evaluate different valuation possibilities.
- User-Centric Interface: Intuitive, organized, and suitable for both seasoned professionals and newcomers.
How It Works
- Step 1: Download the Excel file for Aditxt, Inc. (ADTX).
- Step 2: Review Aditxt's pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust the assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment decisions.
Why Choose Aditxt, Inc. (ADTX)?
- Save Time: Skip the lengthy processes – our solutions are ready for immediate use.
- Enhance Precision: Access to accurate data and algorithms minimizes valuation errors.
- Completely Customizable: Adjust the platform to fit your unique strategies and forecasts.
- User-Friendly: Intuitive interfaces and visuals make insights straightforward to understand.
- Endorsed by Professionals: Crafted for experts who prioritize accuracy and functionality.
Who Should Use This Product?
- Professional Investors: Create comprehensive and accurate valuation models for Aditxt, Inc. (ADTX) analysis.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights to clients interested in Aditxt, Inc. (ADTX).
- Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling.
- Health Tech Enthusiasts: Gain insights into the valuation of innovative health tech companies like Aditxt, Inc. (ADTX).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Aditxt, Inc. (ADTX) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Aditxt, Inc. (ADTX).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.